Literature DB >> 30891613

Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.

Hai Cheng1, Xue Wang1, Dian Zhou1, Jiang Cao1, Andre Larochelle2, Kai-Lin Xu3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30891613      PMCID： PMC6855301          DOI： 10.1007/s00277-019-03658-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

Authors:  Ronan Desmond; Danielle M Townsley; Bogdan Dumitriu; Matthew J Olnes; Phillip Scheinberg; Margaret Bevans; Ankur R Parikh; Kinneret Broder; Katherine R Calvo; Colin O Wu; Neal S Young; Cynthia E Dunbar
Journal:  Blood       Date:  2013-12-17       Impact factor: 22.113

2.  Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.

Authors:  Danielle M Townsley; Phillip Scheinberg; Thomas Winkler; Ronan Desmond; Bogdan Dumitriu; Olga Rios; Barbara Weinstein; Janet Valdez; Jennifer Lotter; Xingmin Feng; Marie Desierto; Harshraj Leuva; Margaret Bevans; Colin Wu; Andre Larochelle; Katherine R Calvo; Cynthia E Dunbar; Neal S Young
Journal:  N Engl J Med       Date:  2017-04-20       Impact factor: 91.245

3.  Eltrombopag as initial monotherapy for severe aplastic anemia-a case report.

Authors:  George M Rodgers; Jeffrey A Gilreath
Journal:  Ann Hematol       Date:  2018-03-20       Impact factor: 3.673

4.  Eltrombopag and improved hematopoiesis in refractory aplastic anemia.

Authors:  Matthew J Olnes; Phillip Scheinberg; Katherine R Calvo; Ronan Desmond; Yong Tang; Bogdan Dumitriu; Ankur R Parikh; Susan Soto; Angelique Biancotto; Xingmin Feng; Jay Lozier; Colin O Wu; Neal S Young; Cynthia E Dunbar
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245
  4 in total
  2 in total

1.  Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study.

Authors:  Yali Du; Yuzhou Huang; Wenzhe Zhou; Xinjian Liu; Fangfei Chen; Chen Yang; Miao Chen; Jing Ruan; Bing Han
Journal:  Drug Des Devel Ther       Date:  2020-12-30       Impact factor: 4.162

2.  Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.

Authors:  Anastasia Martynova; Victor Chiu; Melissa Mert; David Hermel; Ilene Ceil Weitz
Journal:  Ann Hematol       Date:  2021-01-09       Impact factor: 3.673
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.